-
Aimmune Therapeutics Inc. (AIMT $34.49)
- $34.49 Cap: $2.25B
- View AIMT Profile
- View Questions on AIMT
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Aimmune Therapeutics Inc. (AIMT $34.49)
- $34.49 Cap: $2.25B
- View AIMT Profile
- View Questions on AIMT
-
DBV Technologies S.A. (DBVT $9.50)
- $9.50 Cap: $268M
- View DBVT Profile
- View Questions on DBVT
Q: Holding both AIMT and DBVT. Appreciate you comments. Thanks
-
Aimmune Therapeutics Inc. (AIMT $34.49)
- $34.49 Cap: $2.25B
- View AIMT Profile
- View Questions on AIMT
Q: I hope I can get your thoughts on AIMT please.
Insiders
Share Information
SEC Filings
News and Media